Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1132353

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1132353

Hypertension Drug Market Share, Size, Trends, Industry Analysis Report, By Distribution Channel ; By Condition ; By Type; By Medication Type; By Region; Segment Forecast, 2022 - 2030

PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

Description

Table of Contents

List of Tables

The global hypertension drug market size is expected to reach USD 31.52 billion by 2030, according to a new study by Polaris Market Research. The report "Hypertension Drug Market Share, Size, Trends, Industry Analysis Report, By Distribution Channel (Retail Pharmacies, E-Commerce Pharmacies, Hospital Pharmacies); By Condition (Primary, Secondary); By Type; By Medication Type; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

High growth in hypertension drugs is mainly due to an increase in hypertension patients, an increase in tobacco consumption, and government initiatives. A constant workload and unhealthy eating habits are the leading causes of hypertension. These factors have contributed to the rise in cases of hypertension.

Globally, the number of hypertension cases has increased significantly. In addition, there is a critical need to raise awareness about the complications associated with hypertension. The significant driver of the global market's growth.

The global market for hypertension medications is expanding due to the epidemic rise in the prevalence of hypertension. Studies have revealed that hypertension has developed into a condition that, if untreated in the beginning stages, can progress and become a fatal condition that may affect the patient's heart. In an effort to increase public awareness, the effects of hypertension are being made more widely known. In the recent past, the world has become more digital, which has resulted in a situation where lifestyles are becoming more sedentary.

Hypertension Drug Market Report Highlights

Angiotensin II Receptor Blockers segment is anticipated to grow at a significant rate over the forecast period owing to the rising high blood pressure, heart failure, and chronic kidney disease.

Primary hypertension accounted for a major revenue share. It's linked to genetics, lack of exercise, a deficient diet, an excessive amount of salt and obesity. It is by far the most common form of primary hypertension

North America is expected to grow at a significant CAGR over the projected period on account of the increasing consumer awareness regarding the adverse of high blood pressure, obesity etc. which cause several diseases such as cancer and other cardiovascular disorders

The global market is highly competitive due to the existence of large market players with a global presence, including Takeda Pharmaceutical Co., Pfizer, Inc., Astra Zeneca Plc, Dr. Reddy's Laboratories, Novartis, Abbott, Sanofi, and Bayer AG

Polaris Market Research has segmented the hypertension drug market report based on type, condition, medication, distribution channel and region:

Hypertension Drug, Type Outlook (Revenue - USD Billion, 2018 - 2030)

Diuretics

Alpha-Blockers

Calcium Channel Blockers

Beta blockers

Angiotensin-Converting Enzyme (ACE)

Inhibitors

Renin Inhibitors

Angiotensin II Receptor Blockers (ARBs)

Vasodilators

Others

Hypertension Drug, Condition Outlook (Revenue - USD Billion, 2018 - 2030)

Primary

Secondary

Hypertension Drug, Medication Outlook (Revenue - USD Billion, 2018 - 2030)

Combination Therapy

Monotherapy

Fixed Dose Combinations Pharmacies

Hypertension Drug, Distribution Channel Outlook (Revenue - USD Billion, 2018 - 2030)

Retail Pharmacies

E-Commerce Pharmacies

Hospital Pharmacies

Hypertension Drugs, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Show more
Product Code: PM1331

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Hypertension Drug Market Insights

  • 4.1. Hypertension Drug - Industry Snapshot
  • 4.2. Hypertension Drug Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. High growth potential in developing economies
      • 4.2.1.2. Surge in healthcare expenditure worldwide
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Rising healthcare costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Hypertension Drug Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Hypertension Drug Market, by Condition

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • 5.3. Primary
    • 5.3.1. Global Hypertension Drug Market, by Primary, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Secondary
    • 5.4.1. Global Hypertension Drug Market, by Secondary, by Region, 2018 - 2030 (USD Billion)

6. Global Hypertension Drug Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • 6.3. Retail Pharmacies
    • 6.3.1. Global Hypertension Drug Market, by Retail Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 6.4. E-Commerce Pharmacies
    • 6.4.1. Global Hypertension Drug Market, by E-Commerce Pharmacies, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Hospital Pharmacies
    • 6.5.1. Global Hypertension Drug Market, by Hospital Pharmacies, by Region, 2018 - 2030 (USD Billion)

7. Global Hypertension Drug Market, by Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • 7.3. Diuretics, Alpha-Blockers
    • 7.3.1. Global Hypertension Drug Market, by Diuretics, Alpha-Blockers, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Calcium Channel Blockers
    • 7.4.1. Global Hypertension Drug Market, by Calcium Channel Blockers, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Beta blockers
    • 7.5.1. Global Hypertension Drug Market, by Beta blockers, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Angiotensin-Converting Enzyme (A.C.E.)
    • 7.6.1. Global Hypertension Drug Market, by Angiotensin-Converting Enzyme (A.C.E.), by Region, 2018 - 2030 (USD Billion)
  • 7.7. Inhibitors
    • 7.7.1. Global Hypertension Drug Market, by Inhibitors, by Region, 2018 - 2030 (USD Billion)
  • 7.8. Renin Inhibitors
    • 7.8.1. Global Hypertension Drug Market, by Renin Inhibitors, by Region, 2018 - 2030 (USD Billion)
  • 7.9. Angiotensin II Receptor Blockers (A.R.B.s)
    • 7.9.1. Global Hypertension Drug Market, by Angiotensin II Receptor Blockers (A.R.B.s), by Region, 2018 - 2030 (USD Billion)
  • 7.10. Vasodilators
    • 7.10.1. Global Hypertension Drug Market, by Vasodilators, by Region, 2018 - 2030 (USD Billion)
  • 7.11. Others
    • 7.11.1. Global Other Hypertension Drug Market, by Region, 2018 - 2030 (USD Billion)

8. Global Hypertension Drug Market, by Medication Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • 8.3. Combination Therapy
    • 8.3.1. Global Hypertension Drug Market, by Combination Therapy, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Monotherapy
    • 8.4.1. Global Hypertension Drug Market, by Monotherapy, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Fixed Dose Combinations
    • 8.5.1. Global Hypertension Drug Market, by Fixed Dose Combinations, by Region, 2018 - 2030 (USD Billion)

9. Global Hypertension Drug Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Hypertension Drug Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Hypertension Drug Market - North America
    • 9.3.1. North America: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.3.5. Hypertension Drug Market - U.S.
      • 9.3.5.1. U.S.: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.3.6. Hypertension Drug Market - Canada
      • 9.3.6.1. Canada: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • 9.4. Hypertension Drug Market - Europe
    • 9.4.1. Europe: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.5. Hypertension Drug Market - UK
      • 9.4.5.1. UK: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.6. Hypertension Drug Market - France
      • 9.4.6.1. France: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.7. Hypertension Drug Market - Germany
      • 9.4.7.1. Germany: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.8. Hypertension Drug Market - Italy
      • 9.4.8.1. Italy: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.9. Hypertension Drug Market - Spain
      • 9.4.9.1. Spain: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.10. Hypertension Drug Market - Netherlands
      • 9.4.10.1. Netherlands: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.4.11. Hypertension Drug Market - Russia
      • 9.4.11.1. Russia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Russia.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Russia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Russia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • 9.5. Hypertension Drug Market - Asia Pacific
    • 9.5.1. Asia Pacific: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.5. Hypertension Drug Market - China
      • 9.5.5.1. China: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.6. Hypertension Drug Market - India
      • 9.5.6.1. India: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.7. Hypertension Drug Market - Japan
      • 9.5.7.1. Japan: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.8. Hypertension Drug Market - Malaysia
      • 9.5.8.1. Malaysia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.9. Hypertension Drug Market - Indonesia
      • 9.5.9.1. Indonesia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.5.10. Hypertension Drug Market - South Korea
      • 9.5.10.1. South Korea: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • 9.6. Hypertension Drug Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.5. Hypertension Drug Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.6. Hypertension Drug Market - South Africa
      • 9.6.6.1. South Africa: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.7. Hypertension Drug Market - Israel
      • 9.6.7.1. Israel: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.6.8. Hypertension Drug Market - UAE
      • 9.6.8.1. UAE: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • 9.7. Hypertension Drug Market - Latin America
    • 9.7.1. Latin America: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.5. Hypertension Drug Market - Mexico
      • 9.7.5.1. Mexico: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.6. Hypertension Drug Market - Brazil
      • 9.7.6.1. Brazil: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
    • 9.7.7. Hypertension Drug Market - Argentina
      • 9.7.7.1. Argentina: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Takeda Pharmaceutical Co
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Pfizer, Inc
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Astra Zeneca Plc
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Dr. Reddy's Laboratories
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Novartis, Abbott
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Sanofi
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Bayer AG
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Johnson and Johnson Services Inc
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Gilead
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. GlaxoSmithKline Plc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Merck & Co. Inc
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Actelion Ltd.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. F. Hoffmann La-Roche Ltd
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
Show more
Product Code: PM1331

List of Tables

  • Table 1 Global Hypertension Drug Market, by Condition, by Region, 2018 - 2030 (USD Billion)
  • Table 2 Global Hypertension Drug Market, by Distribution Channel, by Region, 2018 - 2030 (USD Billion)
  • Table 3 Global Hypertension Drug Market, by Type, by Region, 2018 - 2030 (USD Billion)
  • Table 4 Global Hypertension Drug Market, by Medication Type, by Region, 2018 - 2030 (USD Billion)
  • Table 5 Hypertension Drug Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • Table 6 North America: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 7 North America: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 8 North America: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 9 North America: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 10 U.S.: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 11 U.S.: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 12 U.S.: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 13 U.S.: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 14 Canada: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 15 Canada: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 16 Canada: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 17 Canada: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 18 Europe: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 19 Europe: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 20 Europe: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 21 Europe: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 22 Germany: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 23 Germany: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 24 Germany: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 25 Germany: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 26 France: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 27 France: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 France: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 29 France: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 30 UK: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 31 UK: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 32 UK: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 33 UK: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 34 Italy: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 35 Italy: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 36 Italy: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 37 Italy: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 38 Netherlands: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 39 Netherlands: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Netherlands: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 41 Netherlands: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 42 Spain: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 43 Spain: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 44 Spain: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 45 Spain: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 46 Russia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 47 Russia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 48 Russia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 49 Russia: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 54 China: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 55 China: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 56 China: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 57 China: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 58 Japan: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 59 Japan: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 60 Japan: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 61 Japan: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 62 India: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 63 India: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 64 India: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 65 India: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 66 Indonesia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 67 Indonesia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 68 Indonesia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 69 Indonesia: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 70 Malaysia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 71 Malaysia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 72 Malaysia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 73 Malaysia: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 74 South Korea: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 75 South Korea: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 76 South Korea: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 77 South Korea: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 78 Latin America: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 79 Latin America: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 80 Latin America: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 81 Latin America: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 82 Brazil: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 83 Brazil: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 84 Brazil: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 85 Brazil: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 86 Mexico: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 87 Mexico: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 88 Mexico: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 89 Mexico: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 90 Argentina: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 91 Argentina: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 92 Argentina: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 93 Argentina: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 94 Middle East & Africa: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 95 Middle East & Africa: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 96 Middle East & Africa: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 97 Middle East & Africa: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 98 UAE: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 99 UAE: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 100 UAE: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 101 UAE: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 102 Saudi Arabia: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 103 Saudi Arabia: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 104 Saudi Arabia: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 105 Saudi Arabia: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 106 South Africa: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 107 South Africa: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 108 South Africa: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 109 South Africa: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)
  • Table 110 Israel: Hypertension Drug Market, by Condition, 2018 - 2030 (USD Billion)
  • Table 111 Israel: Hypertension Drug Market, by Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 112 Israel: Hypertension Drug Market, by Type, 2018 - 2030 (USD Billion)
  • Table 113 Israel: Hypertension Drug Market, by Medication Type, 2018 - 2030 (USD Billion)

List of Figures

Figure 1. Global Hypertension Drug Market, 2018 - 2030 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Medication Type

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Condition

Figure 7. Global Hypertension Drug Market, by Condition, 2021 & 2030 (USD Billion)

Figure 8. Market by Medication Type

Figure 9. Global Hypertension Drug Market, by Medication Type, 2021 & 2030 (USD Billion)

Figure 10. Market by Distribution Channel

Figure 11. Global Hypertension Drug Market, by Distribution Channel, 2021 & 2030 (USD Billion)

Figure 12. Market by Type

Figure 13. Global Hypertension Drug Market, by Type, 2021 & 2030 (USD Billion)

Figure 14. Hypertension Drug Market Assessment, By Geography, 2018 - 2030 (USD Billion)

Figure 15. Strategic Analysis - Hypertension Drug Market

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!